Shane Kelly - Chief Executive Officer.

Shane has extensive experience in financing, operating and managing early and mid size growth companies. [more]

Lloyd Payne - PhD, Chief Scientific Officer.

Dr Payne was previously a senior scientist at Millennium Pharmaceuticals where he was responsible for the leadership of multidisciplinary drug discovery project teams based in the UK and the US. [more]

Mike Birch - PhD, Vice President of Operations

Mike is one of the original members of the F2G scientific staff and has been instrumental in the development of F2G’s core MycoBank technology. [more]

Raman Minhas - Head of Corporate Development

During his career Raman has advised on healthcare business development and financing transactions totalling over $50 million. [more]